Reduction in neutrophil cell surface expression of tumor necrosis factor receptors but not Fas after transmigration: Implications for the regulation of neutrophil apoptosis

Archives of Surgery

Volumn 133, Issue 12, 1998, Pages 1305-1310

  Seely, Andrew J E ^a   Swartz, Daniel E ^a   Giannias, Betty ^b   Christou, Nicolas V ^b  

^a MCGILL UNIVERSITY   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; FAS ANTIGEN; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL MIGRATION; CELL SURVIVAL; DATA ANALYSIS; EXUDATE; FLOW CYTOMETRY; HUMAN; HUMAN EXPERIMENT; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; VEIN PUNCTURE;

ANTIGENS, CD95; APOPTOSIS; EXUDATES AND TRANSUDATES; HUMANS; NEUTROPHILS; PROSPECTIVE STUDIES; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032406708     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.133.12.1305     Document Type: Article

References (25)

1. Ward PA, Varani J. Mechanisms of neutrophil-mediated killing of endothelial cells. J Leukoc Biol. 1990;48:97-101.
2. Tanaka H, Sugimoto H, Yoshioka T, Sugimoto T. Role of granulocyte elastase in tissue injury in patients with septic shock complicated by multiple organ failure. Ann Surg. 1991;213:81-85.
3. Chollet-Martin S, Jourdain B, Gibert C, et al. Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS. Am J Respir Crit Care Med. 1996;154:594-601.
4. Sinclair DG, Braude S, Haslam PL, Evans TW. Pulmonary endothelial permeability in patients with severe lung injury: clinical correlates and natural history. Chest. 1994;106:535-539.
5. Poggetti RS, Moore FA, Moore EE, et al. Liver injury is a reversible neutrophil-mediated event following gut ischemia. Arch Surg. 1992;127:175-179.
6. Koike K, Moore EE, Moore FA, et al. CD11b blockade prevents lung injury despite neutrophil priming after gut ischemia/reperfusion. J Trauma. 1995;39:23-28.
7. Ridings PC, Windsor AC, Jutila MA, et al. A dual-binding antibody to E- and L-selectin attenuates sepsis-induced lung injury. Am J Respir Crit Care Med. 1995;152:247-253.
8. Haslett C. Resolution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes. Clin Sci. 1992;83:639-648.
9. Haslett C, Savill JS, Lee A, Wyllie AH, Henson PM. Apoptosis in ageing neutrophils leads to recognition by macrophages. J Leukoc Biol. 1987;42:395-399.
10. Haslett C. Granulocyte apoptosis and inflammatory disease. Br Med Bull. 1997;53:669-683.
11. Yee J, Giannias B, Kapadia B, Chartrand L, Christou NV. Exudative neutrophils: modulation of microbicidal function in the inflammatory microenvironment. Arch Surg. 1994;129:99-105.
12. Zimmerli W, Gallin JI. Monocytes accumulate on rebuck skin window coverslips but not in skin chamber fluid. J Immunol Methods. 1987;96:11-17.
13. Martin SJ, Reutelingsperger CP, McGahon AJ, et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med. 1995;182:1545-1556.
14. Koopman G, Reutelingsperger CP, Kuijten GA, et al. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 1994;84:1415-1420.
15. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein-labelled annexin V. J Immunol Methods. 1995;184:39-51.
16. Watson RWG, Rotstein OD, Nathens AB, Parodo J, Marshall JC. Neutrophil apoptosis is modulated by endothelial transmigration and adhesion molecule engagement. J Immunol. 1997;158:945-953.
17. Richter J, Zetterberg E. L-Selectin mediates downregulation of neutrophil TNF receptors. J Leukoc Biol. 1990;56:525-527.
18. Porteu F, Nathan C. Shedding of tumour necrosis factor receptors by activated human neutrophils. J Exp Med. 1990;172:599-607.
19. Schleiffenbaum B, Fehr J. The tumour necrosis factor receptor and human neutrophil function. J Clin Invest. 1990;86:184-195.
20. Nagata S. Fas and Fas ligand: a death factor and its receptor. Adv Immunol. 1994;57:129-144.
21. Dhein J, Walczak C, Baumler K, Debatin K, Krammer PH. Autocrine T-cell suicide mediated by AP0-1/(Fas/CD95). Nature. 1995;373:444-448.
22. Alderson MR, Tough TW, Davis-Smith T, et al. Fas ligand mediates activation induced cell death in human T lymphocytes. J Exp Med. 1995;181:71-77.
23. Liles WC, Kiener PA, Ledbetter JA, Aruffo A, Klebanoff SJ. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J Exp Med. 1996;184:429-440.
24. Tanaka M, Suda T, Takahashi T, Nagata S. Expression of the functionally soluble form of human Fas ligand in activated lymphocytes. Eur Mol Biol Organ. 1995;14:1129-1135.
25. Watson RWG, Redmond HP, Wang JH, Condron C, Bouchier-Hayes D. Neutrophils undergo apoptosis following ingestion of Escherichia coli. J Immunol. 1996;156:3986-3992.